This presentation discusses Meniere's disease and its current management trends

1. Dr T Balasubramanian MS DLO
www.drtbalu.com
1

2. Meniere’s disease is defined as a symptom complex associated with:
1. Roaring tinnitus
2. Sensorineural hearing loss (Low frequency)
3. Vertigo (episodic)
4. Fullness of the ear
5. These symptoms are associated with dilated membranous
labyrinth filled with endolymph
www.drtbalu.com
2

3. 1. 1747 – Antonio Scarpa described anatomy of membranous
labyrinth
2. 1861 – Prosper Meniere described the classic features of
Meniere’s disease & attributed it to labyrinthine causes
3. 1871 – Knappin theorized that dilated membranous labyrinth to
be the cause of this disorder
4. 1927 – Guild described endolymphatic ciruclation
5. 1938 – Hallpike and Portmann described pathology of Meniere’s
disease by studying temporal bones.
www.drtbalu.com
3

4. 1. 150 years have passed since this syndrome was described
2. Amount of literature accumulated has virtually doubled
3. Only consensus reached so far is that its cause is multifactorial
4. Not all individuals with histological features of Meniere’s disease
manifested the classic clinical features (? Unknown factors
protecting the individuals)
5. Surgical destruction of sac ameliorates symptoms. (? What role
does sac play exactly in endolymphatic circulation)
www.drtbalu.com
4

5. 1. Inner ear contains two types of fluids (perilyimph and endolymph
separated by membranous labyrinth.
2. Perilymph is similar in composition to CSF (Containing high Na and low K
ions)
3. Endolymph similar in composition to intracellular fluid (Containing low Na
and high K concentration). It is secreted by stria vascularis
www.drtbalu.com
5

6.  Duct begins at ductus reuniens
 Duct is a single lumen tube
about 2 mm long
 The duct narrows at the isthmus
which lies at the level of
vestibular aqueduct
www.drtbalu.com
6

7. 1. Secretory function
2. Absorptive function
3. Immune / defense function
www.drtbalu.com
7

8. 1. Aquaporins
2. Glycoproteins like Saccain
3. Endolymph
4. Glycoproteins act as a driving force
for longitudinal flow
www.drtbalu.com
8

9. 1. Longitudinal flow
2. Radial flow
3. Dynamic flow
www.drtbalu.com
9

10. 1. Was first proposed by Guild
2. Striavascularis is the principal source
3. This is a slow process
4. Elimination occurs at the endolymphatic
sac level
www.drtbalu.com
10

11. 1. First proposed by Lawrence
2. This is a combination of both
longitudinal and radial flow patterns
www.drtbalu.com
11

12. 1. This is active process (energy consuming)
2. Production occurs from dark vestibular cells &
planum semilunatum
3. Absorption occurs at the striavestibularis
www.drtbalu.com
12

13. 1. This is a small membranous bulb located where the
endolymphatic duct enters the vestibule
2. This is where the volume of circulating endolymph is monitored
3. Monitoring the volume of endolymph is not possible by sac
because it will be interfered by CSF pressure and pressure
exerted by lateral sinus
www.drtbalu.com
13

14. www.drtbalu.com
14

15. 1. Composition of endolymph is maintained by stria vascularis by controlling
the influx of water
2. Normally endolymph is a biological puddle with very little radial /
longitudinal flow
3. Only under exceptional circumstances like increased endolymphatic fluid
volumes does radial / longitudinal movement towards sac occurs
4. Under normal circumstances radial flow alone is sufficient to maintain
endolymph fluid balance and the longitudinal flow due to saccmechanics is
not necessary
5. The longitudinal flow is restricted by the isthmus portion of the duct which
acts like the constriction seen in the hour glass
www.drtbalu.com
15

16. www.drtbalu.com
16

17. www.drtbalu.com
17

18. www.drtbalu.com
18

19. 1. Small amounts of excess endolymph can be cleared by radial flow
2. Larger volumes need longitudinal flow for their clearance
3. Endolymphatic sinus temporarily accommodates excess endolymph till
the sac is ready for it
4. Endolymphatic valve of Bast isolates pars superior and prevents
endolymph from draining out of the utricle
www.drtbalu.com
19

20. 1. Genetic causes
2. Infection
3. Otosclerosis
4. Trauma (physical / acoustic)
5. Syphilis
6. Miscellaneous – Allergy, tumors, leukemia and autoimmune disorders
www.drtbalu.com
20

21. 1. Classical Meniere’s disease
2. Vestibular Meniere’s disease – vestibular symptoms and aural pressure
3. Cochlear Meniere’s disease – cochlear symptoms and aural pressure
4. Lermoyez syndrome – Reverse Meniere’s
5. Tumarkin’s crisis – Utricular Meniere’s
www.drtbalu.com
21

22. This is a variant of Meniere’s disease. It is characterized by sudden sensori
neural hearing loss which improves during or immediately after the attack of
vertigo.
www.drtbalu.com
22

23. This variant is characterized by abrupt falling attacks of brief duration
without loss of consciousness. This is caused due to an enlarging utricle
due to excess endolymphatic volume. Utricular crisis is used to indicate
this condition.
In the later disease stages the valve of Bast remaining patent may cause
sudden drainage of endolymph from the utricle due to longitudinal flow
resulting in these drop attacks
www.drtbalu.com
23

24.  Roughly 1 in 1000 individuals are affected
 Constitutes 10% of all patients attending vertigo clinic
 Female preponderance
 Rare in children under the age of 10
 Commonly begins between 4th and 5th decades of life
 Bilateral Meniere’s syndrome is seen in 5% of these patients
www.drtbalu.com
24

25. 1. Endolymphatic hydrops causes distortion of membranous labyrinth
2. Pressure building up in the scala media may cause mirco ruptures of
membranous labyrinth
3. This would account for the episodic nature of the attacks
4. Healing of these ruptures causes resolution of the disorder
www.drtbalu.com
25

26. 1. Episodic vertigo rotatory in nature
2. Ipsilateral hearing loss
3. Aural fullness
4. Roaring tinnitus
5. Diplacusis
www.drtbalu.com
26

27. 1. Stage I – Patient has solely cochlear symptoms
2. Stages II – IV – Patients have progressively more cochlear and
vestibular symptoms
3. Stage V – End stage Meniere’s disease (dead ear)
www.drtbalu.com
27

28. 1. Irritative nystagmus during the first 20 mins of attack
2. Paralytic nystagmus follows
3. Later recovery nystagmus starts
www.drtbalu.com
28

29.  Possible Meniere’s disease:
Episodic vertigo of Meniere’s type without documented hearing loss
Fluctuating hearing loss with disequilibrium but without definite episodes
 Probable Meniere’s disease:
One definitive episode of vertigo
Audiometrically documented hearing loss at least during one attack
 Definitive Meniere’s disease
Two or more definitive episodes of spontaneous vertigo one atleast lasting for
20 mins.
 Audiometrically documented hearing loss at least on one occasion
Tinnitus and aural fullness in the treated ear
www.drtbalu.com
29

30.  Sensori neural hearing loss combined with:
Tinnitus now / in the past
Vertigo attacks (at least two present now or in the past)
Exclusion of other pathology following Groningen protocol
 Hearing loss:
Sensori neural in nature
No demonstrable conductive element
Hearing loss of 20 dB or more at one of the usually measured
audiometric thresholds
 Vertigo:
Paroxysmal rotatory dizziness, accompanied by nausea / vomiting
At least two episodes should be reported during a course of illness.
One of the attack should last at least for 5 mins
In between attacks there may be periods of unsteadiness
www.drtbalu.com
30

31. 1. Sensori neural in nature
2. Fluctuating and progressive
3. Affects low frequencies
4. Mild low frequency conductive hearing loss (rare)
5. Profound sensori neural hearing loss (End stage)
www.drtbalu.com
31

32.  Roaring in nature
 Could be continuous / intermittent
 Non pulsatile in nature
 Frequency of tinnitus corresponds to the region of cochlea which has suffered
the maximum damage
www.drtbalu.com
32

33. 1. This is abnormal growth in the perceived intensity of sound
2. This is usually positive in patients with Meniere’s disease
3. ABLB is the test used to look for the presence of recruitment
4. This test is really time consuming
www.drtbalu.com
33

34. 1. Increased summating potential / action potential ratio. 1:3 is normal
2. Widened summating potential / action potential complex. A widening of
greater than 2 ms is significant
3. Small distorted cochlear microphonics
www.drtbalu.com
34

35. 1. Not mandatory for diagnosis of Meniere’s disease
2. Caloric test is still performed
3. It is low frequency stimulation (0.003 Hz) of lateral canal
4. Caloric asymmetry will point to the diseased ear
5. 20% difference between the two ears (Jongkee’s formula) is significant
www.drtbalu.com
35

36. 1. Vestibular evoked myogenic potential
2. Measures the relaxation of sternomastoid muscle in response to ipsilateral click
stimulus
3. Brief high intensity ipsilateral clicks produce large short latency inhibitory
potentials (VEMP) in the toncially contracted Ipsilateral sternomastoid muscle
4. This test is due to the presence of vestibulo collic reflex
5. Afferent arises from sound responsive cells in the saccule, conducted via the
inferior vestibular nerve.
6. Efferent is via vestibulo spinal tract
7. Normal responses are composed of biphasic (positive-negative) waves
8. VEMP reveals saccular dysfunction
www.drtbalu.com
36

37. 1. Glycerol
2. Frusemide
3. Isosorbide
4. Tests are positive if there is pure tone improvement of 10dB or more
at two / more frequencies between 200-2000Hz
www.drtbalu.com
37

38. 1. First introduced by Klockhoff and Lindblom – 1966
2. Glycerol is administered in doses of 1.5 mg/kg body wt in empty stomach
3. Serum osmolality should increase at least by 10 mos/kg
4. Side effects include Headache, Nausea, vomiting, drowsiness
5. PTA is performed 2-3 hours after administration
6. False positivity is rare
7. Positivity depends on the phase of the disease
www.drtbalu.com
38

39. 1. Dietary management
2. Physiotherapy
3. Psychological support
4. Pharmacological intervention
www.drtbalu.com
39

40. 1. Intravenous fluids – dehydration
2. Vestibular suppressants – May delay recovery / rehabilitation process
3. Corticosteroids – May help if tinnitus and deafness are debilitating
www.drtbalu.com
40

41. 1. Frustenberg diet
2. 2 grams / 24 hours (restricted salt intake)
3. Life style modification
www.drtbalu.com
41

42. 1. Diuretics play a vital role in alleviating acute symptoms
2. This has been in use since 1930’s
3. Thiazide group of drugs are commonly used
4. Frusemide may be used to alleviate acute symptoms
5. Clear scientific evidence is lacking regarding the usefulness of diuretics
(cochrane review)
www.drtbalu.com
42

43. 1. Cochlear vascular insufficiency has been proposed as one of the
mechanism of Meniere's disease
2. Betahistine is supposed to cause vasodilatation of cochlear blood
vessels
3. Betahistine has weak H1 agonistic property and considerable H3
antagonist properties
4. It reduces the frequency & intensity of vertigo. Has minimal effect on
tinnitus
5. Doesn’t help much with hearing loss (Cochrane review)
www.drtbalu.com
43

44. 1. Immune modulating effects
2. Improves fluid dynamics of inner ear due to mineralocorticoid effects
3. Vertigo was controlled on an immediate basis
4. Methylprednisolone has the best effect as it penetrates the round window
better
5. Silverstein microwick can be used for intratympanic drug administration
www.drtbalu.com
44

45. 1. Isordil
2. ϒ – globulin
3. Urea
4. Glycerol
5. Lithium
6. Anticholinergics – Glycopyrrolate 1-2 mg /day
7. Antidopaminergics – Droperidol 2.5 – 10 mg orally / day
8. Leuprolide acetate – Blocks normal sex hormone production
9. Innovar – A combination of droperidol and fentanyl can be used to
suppress vestibular symptoms (can replace endolymphatic sac surgery)
10. Hyperbaric oxygen therapy
www.drtbalu.com
45

46. 1. Stress reduction
2. Patient education
3. Hearing aids – can be used to suppress troublesome tinnitus
4. Tinnitus retraining
www.drtbalu.com
46

47. 1. Meniett Device
2. Low pressure pulse generator
3. Vibrations are transmitted via external
auditory canal
4. Vibrations alter inner ear fluid dynamics by
their effects on the oval and round
windows
5. Exact mechanism of action is not known
6. It is totally non invasive
7. This device is portable
www.drtbalu.com
47

48. 1. Diagnosis should be confirmed
2. Ventilation tube should be inserted
3. Patient should be trained for self administration of the treatment
4. Usually administered thrice a day about 5 mins each time
5. Treatment lasts for 5 weeks
www.drtbalu.com
48

49. 1. Classic unilateral Meniere’s disease
2. Intense vestibular / cochlear symptoms
3. Failed medical therapy
4. Over 65 years of age
5. Imbalance / aural fullness / tinnitus after gentamycin treatment
www.drtbalu.com
49

50. 1. Perilymph fistula
2. Acoustic neuroma / brain tumor
3. Retrocochlear damage
4. Low pressure hydrocephalus
www.drtbalu.com
50

51. 1. Vestibulotoxic effects are put to therapeutic use.
2. Sensation of vertigo reduced while hearing is preserved
3. Streptomycin / gentamycin are predominantly Vestibulotoxic
4. Intratympanic administration is preferred
www.drtbalu.com
51

52. 1. Fixed dose protocol is used
2. 40 mg/ml gentamycin is buffered with soda bicarb (pH6.4) final concentration
26.7mg/ml.
3. T tube grommet inserted into the postero inferior quadrant of ear drum. A
mcirocatheter is inserted through the grommet
4. 1ml of gentamycin solution is injected into the middle ear cavity via the
microcatheter
5. Three injections are given per day in outpatient setting
6. Injections are given for 4 days
7. After injection patient should lie supine with the infiltrated ear up for 30 mins
8. Vertigo usually develops between 2-4 days after cessation of treatment
www.drtbalu.com
52

53. 1. Sac enhancement procedure
2. Sac decompression procedure
3. Labyrinthine ablative procedures
www.drtbalu.com
53

54. 1. External shunts – Drains the sac into mastoid cavity / subarachnoid space
2. Internal shunts – Drains excessive endolymph into the perilymphatic space
(cochleosacculotomy / labyrinthotomy)
www.drtbalu.com
54

55. www.drtbalu.com
55

56. 1. Helpful in treating debilitated patients
2. Involves disruption of osseous spiral lamina
3. Angular pick introduced via round window towards oval window. It will
accommodate 3 mm long pick
4. After perforation the pick is withdrawn and the round window is sealed by
fat
www.drtbalu.com
56

57. 1. Labyrinthectomy
2. Translabyrinthine vestibular neurectomy
3. Retrolabyrinthine vestibular neurinectomy
4. Retrosigmoid vestibular neurinectomy
5. Middle cranial fossa vestibular neurinectomy
www.drtbalu.com
57